ELV vs HUM
ELV: Elevance Health is a leading health benefits and services organization providing comprehensive medical, pharmacy, and integrated clinical care solutions to millions of members. HUM: A prominent managed care organization and provider of Medicare Advantage insurance plans.
Side-by-side fundamentals
| Metric | ELV | HUM | Edge |
|---|---|---|---|
| Price as of 2026-10-09 close | $412.70 | $431.87 | |
| Market cap | $89.5B | $51.9B | |
| P/E as of 2026-10-09 | 18.34 | 40.90 | ELV lower |
| PEG as of 2026-10-09, 3-year EPS CAGR to FY2025 | 14.55 | n/a | |
| Net margin FY2025, SEC XBRL | +2.8% | +0.9% | ELV higher |
| Operating margin FY2025, SEC XBRL | +3.6% | +2.1% | ELV higher |
| ROE FY2025, SEC XBRL | +12.9% | +6.7% | ELV higher |
| ROA FY2025, SEC XBRL | +4.7% | +2.4% | ELV higher |
| Debt / equity as of 2026-09-03 | 0.69 | 0.74 | ELV lower |
| Revenue growth (YoY) as of 2026-09-03 | +6.3% | +18.3% | HUM higher |
| Revenue CAGR (3y) SEC XBRL | +8.3% | +11.8% | HUM higher |
| Dividend yield as of 2026-09-03 | +1.7% | +0.9% | ELV higher |
| Dividend streak (yrs) SEC XBRL | 13 | 14 | HUM higher |
| Beta as of 2026-09-03 | 0.23 | 0.48 | |
| 1-year return as of 2026-10-09 close | +15.2% | +48.6% | HUM higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.